CD24 and melanoma: Survival analysis of melanoma patients, stratified by CD24 mRNA expression levels (top 5 percentile), shows a trend towards unfavorable outcome in patients with very high CD24 expression (log rank p-value 0.02) (Supplementary Fig. 2).